Internal Medicine, Hematology & Oncology · Columbus, OH
NPI
1922066778
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
3100 Plaza Properties Blvd
Columbus, OH, 43219
Phone (614) 383-6000
Groups this clinician bills Medicare through
Medicare paid, 2024
$948K
37,157 services
Medicare patients, 2024
187
Average age 74
Drug cost, 2024
$4.8M
813 prescriptions
Company payments, 2025
$32K
From 41 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Tarek Chidiac was code J0185 (injection, aprepitant, 1 mg), 4,420 times for 12 patients. In total Tarek Chidiac billed 37,157 services in 120 codes, and Medicare paid $948K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-02-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0185 Injection, aprepitant, 1 mg | Office | 4,420 | 12 | $1.35 | $5,951 |
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 4,051 | 26 | $0.11 | $428 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 976 | 18 | $0.09 | $86.41 |
| 85025 Blood Count | Office | 363 | 134 | $7.59 | $2,756 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 340 | 12 | $0.73 | $249 |
| 36415 Venipuncture Blood Collection | Office | 336 | 130 | $8.60 | $2,889 |
| 99214 Office E&M - Established | Office | 186 | 78 | $88.62 | $16K |
| 99213 Office E&M - Established | Office | 110 | 84 | $62.80 | $6,908 |
| M0010 Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services | Office | 93 | 20 | $70.18 | $6,527 |
| 96413 Chemotherapy Administration | Office | 88 | 21 | $91.44 | $8,047 |
| 96367 Intravenous Infusion, Hydration | Office | 84 | 20 | $19.60 | $1,646 |
| 96375 Injection Administration | Office | 62 | 15 | $11.02 | $683 |
| 99215 Office E&M - Established | Office | 43 | 26 | $131.03 | $5,634 |
| 71260 CT/CTA - Chest | Office | 39 | 25 | $40.54 | $1,581 |
| 74177 CT/CTA - Abdomen and Pelvis | Office | 38 | 25 | $155.32 | $5,902 |
By year: 2022 $823K for 43,314 services; 2023 $882K for 41,145 services; 2024 $948K for 37,157 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 363 | 134 | $7.59 | $2,756 |
| 36415 Venipuncture Blood Collection | 336 | 130 | $8.60 | $2,889 |
Medicare prescription drug claims, 2024
In 2024, the drug Tarek Chidiac prescribed most often to Medicare patients was Revlimid (Lenalidomide), with 76 prescriptions and refills. In total Tarek Chidiac wrote 813 Medicare prescriptions that cost $4.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Revlimid Lenalidomide | 76 | 76 | Under 11 | $1.3M |
| Brukinsa Zanubrutinib | 41 | 41 | Under 11 | $586K |
| Ondansetron Hcl Generic | 36 | 36 | 22 | $540 |
| Doptelet Avatrombopag Maleate | 36 | 38 | Under 11 | $496K |
| Oxycodone Hcl Generic | 35 | 35 | 23 | $623 |
| Prednisone Generic | 32 | 46 | 15 | $139 |
| Hydroxyurea Generic | 29 | 62 | Under 11 | $460 |
| Gabapentin Generic | 28 | 32 | Under 11 | $241 |
| Letrozole Generic | 25 | 69 | 11 | $612 |
| Eliquis Apixaban | 23 | 33 | Under 11 | $19K |
| Calquence Acalabrutinib Maleate | 23 | 23 | Under 11 | $351K |
| Ibrance Palbociclib | 22 | 22 | Under 11 | $346K |
| Methylprednisolone Generic | 22 | 22 | 15 | $113 |
| Tamsulosin Hcl Generic | 22 | 40 | Under 11 | $302 |
| Lenalidomide Generic | 21 | 21 | Under 11 | $242K |
Brand drugs: 332 claims; generic drugs: 481 claims; opioid claims: 75.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Tarek Chidiac $32K ($32K in general payments such as food, travel and fees) from 41 companies. The largest payer was Regeneron Healthcare Solutions, Inc. with $10K.
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. REGN | 11 | $10K |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 5 | $7,976 |
| Geron Corporation GERN | 5 | $5,249 |
| Avyxa Pharma, LLC | 7 | $5,237 |
| Array Biopharma Inc PFE | 4 | $780 |
| E.R. Squibb & Sons, L.L.C. BMY | 4 | $631 |
| AstraZeneca Pharmaceuticals LP AZN | 6 | $593 |
| Abbvie Inc. ABBV | 8 | $183 |
| BeiGene USA, Inc. ONC | 1 | $141 |
| Eisai Inc. 4523.T | 4 | $111 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.